Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Drug Alcohol Depend. 2008 Mar 10;95(3):230–236. doi: 10.1016/j.drugalcdep.2008.01.010

Table 2.

Means and standard deviations of WAI total scores, drinking outcome, and treatment attendance variables for the total sample and by gender, medication group, and treatment intervention.

Sample N Clinician WAI Total Score1 Patient WAI Total Score2 Percent Days Abstinent Percent Visits Attended3
Total 194 193.8 (26.3) 213.0 (29.5) 85.1 (19.8) 70.9 (30.0)
Male 144 191.7 (25.8) 215.4 (27.4) 86.3 (19.2) 71.9 (29.3)
Female 50 199.4 (27.3) 206.4 (34.2) 81.6 (21.3) 68.1 (32.2)
Naltrexone 103 192.0 (25.7) 215.4 (26.8) 86.6 (17.5) 70.4 (30.5)
Placebo 91 195.3 (26.9) 210.9 (31.6) 83.8 (21.6) 71.4 (29.7)
Doctor Only 64 175.0 (24.7) 203.4 (35.4) 82.3 (21.1) 80.5 (26.2)
BRENDA 67 198.7 (17.0) 215.1 (28.9) 85.3 (19.0) 72.7 (28.5)
CBT 63 208.5 (25.0) 219.7 (21.0) 87.8 (19.1) 59.4 (31.8)
1

For Clinician WAI Total Score - Doctor Only < BRENDA < CBT (p < .0001)

2

For Patient WAI Total Score - Doctor Only < BRENDA = CBT (p < .01)

3

For Percent Visits Attended - Doctor Only = BRENDA > CBT (p < .001)